Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: PDAF, estrogen receptor binding site associated, antigen, 9, EB9
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 100 μL | $270 | 7-10 days | 7-10 days |
| Description | Anti-EBAG9 Antibody (7Y486) is a Rabbit antibody targeting EBAG9. Anti-EBAG9 Antibody (7Y486) can be used in ELISA,WB. |
| Synonyms | PDAF, estrogen receptor binding site associated, antigen, 9, EB9 |
| Ig Type | Rabbit IgG |
| Clone | 7Y486 |
| Reactivity | Human |
| Specificity | Human EBAG9 |
| Application | |
| Recommended Dose | WB: 1:500-1:2000; ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human RCAS1 / EBAG9 (rh RCAS1 / EBAG9; TMPY-03496; O00559; Arg28-Ser213). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | RCAS1, also known as EBAG9, is a tumor-associated antigen that is expressed at high frequency in a variety of cancers. RCAS1 gene was identified as an estrogen-responsive gene. Regulation of transcription by estrogen is mediated by estrogen receptor which binds to the estrogen-responsive element (ERE) found in the 5'-flanking region of RCAS1 gene. Two transcript variants differing in the 5' UTR, but encoding the same protein, have been identified for RCAS1 gene. EBAG9 may participate in suppression of cell proliferation and induces apoptotic cell death through activation of interleukin-1-beta converting enzyme (ICE)-like proteases. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human RCAS1 / EBAG9 Protein (TMPY-03496) |
| Antigen Species | Human |
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.